Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_993a4bfba1bfa31d5a320d9e680769c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fc5210ad36dce22387934b7a2fb8d42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f30320139fc84b9ba4298e51d0137f16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef9b262e05836a02d9ef203f65e7131b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
filingDate |
2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cae1c3fb4f67ce11e7555597fbfd6c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b679abb4589009f1be4055d2f22ee68c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabb78882b1e7c106015679a799aafed |
publicationDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011161223-A3 |
titleOfInvention |
Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
abstract |
The invention relates to unitary pharmaceutical oral dosage forms of the active substances lercanidipine and enalapril, as well the pharmacologically acceptable salts thereof, characterized in that the pharmaceutical oral dosage form comprise separate entities of lercanidipine or its pharmaceutically acceptable salts and enalapril or its pharmaceutically acceptable salts. |
priorityDate |
2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |